Cited by 172Rheumatoid Arthritis Research and TherapiesSchizophrenia research and treatmentGenetic Associations and Epidemiology

The DOI matches its Crossref record; 119 of the 120 references it cites were found in a registry or an index.

Schizophrenia and rheumatoid arthritis: a review

Open access

Eaton, William W, Hayward, Chris, Ram, Ranganathan·1992·Schizophrenia Research

DOI 10.1016/0920-9964(92)90001-l

Open this paper in CoChat — free account Open PDF

Abstract

Fourteen epidemiologic studies of the relationship of rheumatoid arthritis to schizophrenia have been conducted between 1934 and 1985. Twelve of the studies report a lower-than-expected rate of rheumatoid arthritis in populations of schizophrenics. Methodologic weaknesses in the studies are assessed. Nutritional, hormonal, psychosocial, genetic, and immunologic data and theories are briefly reviewed which might explain the epidemiologic results. There is sufficient evidence for the negative association between the two disorders to justify further research.

Integrity signals

Registry

Crossref · 10.1016/0920-9964(92)90001-l

Cites

119 of 119 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis
Šťastný, P. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804202981602 · Cited by 1,169
Harrison's Principles of Internal Medicine.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-6-918_1 · Cited by 1,100
THE EPIDEMIOLOGY OF RHEUMATOID ARTHRITIS IN ROCHESTER MINNESOTA: A STUDY OF INCIDENCE, PREVALENCE, AND MORTALITY1
Linos, A., Worthington, J. W., O'Fallon, M. W., & Kurland, L. T. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112878 · Cited by 402
Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups
Stokes, P. E. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790140047006 · Cited by 364
Arthritis and allied conditions
Ball, G. V. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780221230 · Cited by 335
Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.
Panayi, G. S., Wooley, P. H., & Batchelor, J. R. (1978) · BMJ · doi:10.1136/bmj.2.6148.1326 · Cited by 322
Overview: a current perspective on twin studies of schizophrenia
Kendler, K. S. (1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.11.1413 · Cited by 314
The 24-Hour Dexamethasone Suppression Test in a Clinical Setting: Relationship to Diagnosis, Symptoms, and Response to Treatment
Brown, W. A., Johnston, R., & Mayfield, D. G. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.1979.136.4b.543 · Cited by 250
Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
Zarrabi, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 230
Studies of Depressive Symptoms in Schizophrenia
Johnson, D. A. W. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.139.2.89 · Cited by 219

Show all 120 references

Research works printed but not linked: 6

Amar, 1988, HLA Schizophrenia in Israel, Isr. J. Med. Sci., 24, 28
Chouinard, 1978, A controlled study of tryptophan-beneserazide in schizophrenia, Commun. Psychopharmacol., 2, 21
Cox, 1976, RA and alpha-1 antitrypsin, Lancet, i, 1216
Khoroshko, 1912, Reactii Zivotnogo Organizma na Vvedenie Nervnoi Tkani, Neurotoxini Anaphylaksia Endoxini
DeLisi, 1986, Is schizophrenia a viral or immunologic disorder, Psychiatr. Clin. North Am., 9, 115, 10.1016/S0193-953X(18)30638-5 · DOI
Trevathan, 1954, Rarity of concurrence of psychosis and rheumatoid arthritis in individual patients, J. Nerv. Ment. Dis., 120, 83

Sorted by citations

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Excess early mortality in schizophrenia.
Laursen, T. M., Nordentoft, M., & Mortensen, P. B. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153657 · Cited by 913
Physical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
Medical Comorbidity in Schizophrenia
Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., & Lacro, J. P. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.413 · Cited by 617
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., & Mortensen, P. B. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.521 · Cited by 527
Self-citation
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K., Jung, H., & Kim, Y. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 434
Medical Morbidity, Mental Illness, and Substance Use Disorders
Dickey, B., Normand, S. T., Weiss, R. D., Drake, R. E., & Azeni, H. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.7.861 · Cited by 397
Immune signalling in neural development, synaptic plasticity and disease
Boulanger, L. M., & Shatz, C. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1428 · Cited by 334
Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
Peet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329
Epidemiology of Schizophrenia: Review of Findings and Myths
Messias, E., Chen, C., & Eaton, W. W. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.007 · Cited by 307
Self-citation
Inflammation and the two-hit hypothesis of schizophrenia
Feigenson, K. A., Kusnecov, A., & Silverstein, S. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.11.006 · Cited by 293
Norepinephrine, the β-Adrenergic Receptor, and Immunity
Sanders, V. M., & Straub, R. H. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0639 · Cited by 272
Autoimmune diseases, bipolar disorder, and non-affective psychosis
Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00853.x · Cited by 262
Self-citation
Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling
Severance, E. G., Yolken, R. H., & Eaton, W. W. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.027 · Cited by 260
Self-citation
Medical Comorbidity in Women and Men With Bipolar Disorders: A Population-Based Controlled Study
Carney, C. P., & Jones, L. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000237316.09601.88 · Cited by 229
Rheumatoid arthritis
Carmona, L., Cross, M., Williams, B. H. M., Lassere, M. N., & MARCH, L. M. (2010) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2010.10.001 · Cited by 199
A Nationwide Study on the Risk of Autoimmune Diseases in Individuals With a Personal or a Family History of Schizophrenia and Related Psychosis
Benros, M. E., Pedersen, M. G., Rasmussen, H., Eaton, W. W., Nordentoft, M., & Mortensen, P. B. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13010086 · Cited by 192
Self-citation
The Epidemiologic Evidence Linking Autoimmune Diseases and Psychosis
Benros, M. E., Eaton, W. W., & Mortensen, P. B. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.023 · Cited by 196
Self-citation
Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study
Chen, S.-J., Chao, Y.-L., Chen, C., Chang, C., Wu, E. C., Wu, C., Yeh, H.-H. H., Chen, C., & Tsai, H. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.092098 · Cited by 182
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease
Marrie, R. A., Walld, R., Bolton, J. M., Sareen, J., Walker, J. R., Patten, S. B., Singer, A. G., Lix, L. M., Hitchon, C. A., El-Gabalawy, R. M., et al. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.015 · Cited by 183
Infection and Autoimmunity as Etiologic Factors in Schizophrenia: A Review and Reappraisal
Kirch, D. G. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.2.355 · Cited by 176
Detection and management of comorbidity in patients with schizophrenia
Green, A. I., Canuso, C. M., Brenner, M. J., & Wojcik, J. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00014-x · Cited by 160
Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
Marrie, R. A., Hitchon, C. A., Walld, R., Patten, S. B., Bolton, J. M., Sareen, J., Walker, J. R., Singer, A. G., Lix, L. M., El-Gabalawy, R. M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23539 · Cited by 162
Neuroimmune biomarkers in schizophrenia
Tomasik, J., Rahmoune, H., Guest, P. C., & Bahn, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.07.025 · Cited by 158
Epidemiology and natural history of schizophrenia
Bromet, E. J., & Fennig, S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00153-5 · Cited by 144
Visual Perception Disturbances in Schizophrenia: A Unified Model
Silverstein, S. M. (2016) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-30596-7_4 · Cited by 147
Schizophrenia and HLA: a review
Wright, P., Nimgaonkar, V. L., Donaldson, P. T., & Murray, R. M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00022-0 · Cited by 137
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment
Monteleone, P., Fabrazzo, M., Tortorella, A. A. V., & Maj, M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00036-x · Cited by 134
At Issue: Schizophrenia and Rheumatoid Arthritis: The Negative Association Revisited
Oken, R. J., & Schulzer, M. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033407 · Cited by 129
The Schizophrenia–Rheumatoid Arthritis Connection: Infectious, Immune, or Both?
Torrey, E. F., & Yolken, R. H. (2001) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0649 · Cited by 128
THE NEW EPIDEMIOLOGY OF SCHIZOPHRENIA
Jones, P. B., & Cannon, M. D. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70358-0 · Cited by 114
The complement system: a gateway to gene–environment interactions in schizophrenia pathogenesis
Nimgaonkar, V. L., Prasad, K. M. R., Chowdari, K. V., Severance, E. G., & Yolken, R. H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.151 · Cited by 112
The role of the phosphatidylinositide 3-kinase–protein kinase B pathway in schizophrenia
Kalkman, H. O. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.014 · Cited by 107
Use of large medical databases to study associations between diseases
Goldacre, M. J., Kurina, L. M., Yeates, D., Seagroatt, V. A., & Gill, L. (2000) · QJM · doi:10.1093/qjmed/93.10.669 · Cited by 106
Autoimmune diseases in the pedigrees of schizophrenic and control subjects
Wright, P., Sham, P. C., Gilvarry, C. M., Jones, P. B., Cannon, M. D., Sharma, T., & Murray, R. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(96)82950-1 · Cited by 105
The Cerebral Microvasculature in Schizophrenia: A Laser Capture Microdissection Study
Harris, L. W., Wayland, M. T., Lan, M. J., Ryan, M., Giger, T., Lockstone, H. E., Wüthrich, I., Mimmack, M. L., Wang, L., Kotter, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003964 · Cited by 104
Eicosapentaenoic acid in the treatment of schizophrenia and depression: Rationale and preliminary double-blind clinical trial results
Peet, M. (2003) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.020 · Cited by 103
Family history of autoimmune diseases in psychosis
Gilvarry, C. M., Sham, P. C., Jones, P. B., Cannon, M. D., Wright, P., Lewis, S. W., Bebbington, P., Toone, B., & Murray, R. M. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00045-3 · Cited by 98
Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia
Wright, P., Donaldson, P. T., Underhill, J. A., Choudhuri, K., Doherty, D. G., & Murray, R. M. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1530 · Cited by 95
A population-based register study of the association between schizophrenia and rheumatoid arthritis
Mors, O., Mortensen, P. B., & Ewald, H. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00030-4 · Cited by 87
Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
Sethi, R., Gómez‐Coronado, N., Walker, A. J., Robertson, O. D., Agustini, B., Berk, M., & Dodd, S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00605 · Cited by 90
Genomic imprinting in the development and evolution of psychotic spectrum conditions
Crespi, B. J. (2008) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00050.x · Cited by 87
Schizophrenia: Genetics and the maternal immune response to viral infection
Wright, P., Gill, M., & Murray, R. M. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480110 · Cited by 88
Immunological Aetiology of Major Psychiatric Disorders
Sperner‐Unterweger, B. (2005) · Drugs · doi:10.2165/00003495-200565110-00004 · Cited by 83
Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and Smoking
Yovel, G., Sirota, P., Mazeh, D., Shakhar, G., Rosenne, E., & Ben‐Eliyahu, S. (2000) · Brain Behavior and Immunity · doi:10.1006/brbi.1999.0574 · Cited by 72
Altered interleukin-2 production in schizophrenia: Association between clinical state and autoantibody production
Ganguli, R., Brar, J. S., Solomon, W., Chengappa, K. N. R., & Rabin, B. S. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90046-6 · Cited by 72
The schizophrenic patient in the somatic hospital
Munk‐Jørgensen, P., Mors, O. N., Mortensen, P. B., & Ewald, H. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.00019.x · Cited by 71
Cognition dopamine and bioactive lipids in schizophrenia
Yao, J. K. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s153 · Cited by 67
Decreased Interleukin-2 Production in Korean Schizophrenic Patients
Kim, Y. K., Lee, M. S., & Suh, K. Y. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00357-0 · Cited by 66
Schizophrenia: The Epidemiological Horizon
Jablensky, A. V., Kirkbride, J. B., & Jones, P. B. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch10 · Cited by 66
Serum cytokine concentrations in patients with schizophrenia
Baker, I., Masserano, J. M., & Wyatt, R. J. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00089-5 · Cited by 65
Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level
Gorwood, P. A. P. M., Pouchot, J., Vinceneux, P., Puéchal, X., Flipo, R., Bandt, M. D., & Adès, J. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00017-3 · Cited by 64
The Epidemiological Horizon
Jablensky, A. (2003) · Schizophrenia · doi:10.1002/9780470987353.ch12 · Cited by 59
Can excellent school performance be a precursor of schizophrenia? A 28‐year follow‐up in the Northern Finland 1966 birth cohort
Isohanni, I., Jäwelin, Jones, P., Jokelainen, J., & Isohanni, M. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10909.x · Cited by 69
New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis
Lee, S., Byrne, E. M., Hultman, C. M., Kähler, A. K., Vinkhuyzen, A. A. E., Ripke, S., Andreassen, O. A., Frisell, T., Gusev, A., Hu, X., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv136 · Cited by 60
Molecular genetics of schizophrenia: past, present and future
Prasad, S., Semwal, P., Deshpande, S. N., Triptish Bhatia, A., LNimgaonkar, V., & Thelma, B. K. (2002) · Journal of Biosciences · doi:10.1007/bf02703682 · Cited by 59
Immunity and schizophrenia: Autoimmunity, cytokines, and immune responses
Gaughran, F. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)52013-4 · Cited by 56
Cognitive and Neuroplasticity Mechanisms by Which Congenital or Early Blindness May Confer a Protective Effect Against Schizophrenia
Silverstein, S. M., Wang, Y., & Keane, B. P. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00624 · Cited by 57
Prevalences of autoimmune diseases in schizophrenia, bipolar I and II disorder, and controls
Cremaschi, L., Kardell, M., Johansson, V., Isgren, A., Sellgren, C. M., Altamura, A. C., Hultman, C. M., & Landén, M. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.071 · Cited by 52
Autoimmune phenotypes in schizophrenia reveal novel treatment targets
Severance, E. G., Dickerson, F., & Yolken, R. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.005 · Cited by 52
Microglia dysfunction in schizophrenia: an integrative theory
Munn, N. A. (2000) · Medical Hypotheses · doi:10.1054/mehy.1999.0018 · Cited by 50
Role of Infection, Autoimmunity, Atopic Disorders, and the Immune System in Schizophrenia: Evidence from Epidemiological and Genetic Studies
Benros, M. E., & Mortensen, P. B. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_93 · Cited by 53
Investigation of linkage and association/linkage disequilibrium of HLA A‐, DQA1‐, DQB1‐, and DRB1‐alleles in 69 sib‐pair‐ and 89 trio‐families with schizophrenia
Schwab, S. G., Hallmayer, J. F., Freimann, J., Lerer, B., Albus, M., Borrmann-Hassenbach, M., Segman, R. H., Trixler, M., Rietschel, M., Maier, W., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10307 · Cited by 45
Physical Illness and Schizophrenia
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543951 · Cited by 45
Depression: cost-of-illness studies in the international literature, a review
Berto, P., D'Ilario, D., Ruffo, P., Virgilio, R. D., & Rizzo, F. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/1099-176x(200003)3:1 · Cited by 191
Schizophrenia and the HLA-DRB1 Gene in the Japanese Population
Sasaki, T., Matsushita, M., Nanko, S., Fukuda, R., Kennedy, J. L., & Tokunaga, K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.771 · Cited by 41
Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis
Kling, A., Seddighzadeh, M., Ärlestig, L., Alfredsson, L. S., Rantapää‐Dahlqvist, S., & Padyukov, L. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074948 · Cited by 41
Older people with chronic schizophrenia
Karim, S., Overshott, R., & Burns, A. S. (2005) · Aging & Mental Health · doi:10.1080/13607860500114167 · Cited by 40
Comparative immunogenetics of autism and schizophrenia
Crespi, B. J., & Thiselton, D. L. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00710.x · Cited by 39
Bipolar disorder associated with rheumatoid arthritis: A case-control study
Farhi, A., Cohen, A. D., Shovman, O., Comaneshter, D. S., Amital, H., & Amital, D. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.058 · Cited by 36
Immune related genetic polymorphisms and schizophrenia among the Chinese
Chowdari, K. V., Xu, K., Zhang, F., Ma, C., Li, T., Xie, B. Y., Wood, J. A., Trucco, M., Tsoi, W. F., Saha, N., et al. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00256-7 · Cited by 35
Dosage effects of human ribosomal genes (rDNA) in health and disease
Porokhovnik, L. N., & Lyapunova, N. A. (2018) · Chromosome Research · doi:10.1007/s10577-018-9587-y · Cited by 34
Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms
de la Fontaine, L., Schwarz, M., Riedel, M. J., Dehning, S., Douhet, A., Spellmann, I., Kleindienst, N., Zill, P., Plischke, H., Gruber, R., et al. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2006.01.006 · Cited by 33
Active ribosomal genes, translational homeostasis and oxidative stress in the pathogenesis of schizophrenia and autism
Porokhovnik, L. N., Passekov, V. P., Gorbachevskaya, N. L., Sorokin, A. B., Veiko, N. N., & Lyapunova, N. A. (2015) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000076 · Cited by 30
Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis
Seddighzadeh, M., Korotkova, M., Källberg, H., Ding, B., Daha, N. A., Kurreeman, F. A. S., Toes, R. E. M., Huizinga, T. W. J., Catrina, A. I., Alfredsson, L. S., et al. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.12 · Cited by 29
Duty to Care
Pfrimmer, D. M. (2009) · The Journal of Continuing Education in Nursing · doi:10.3928/00220124-20090201-04 · Cited by 29
Teratogenic alleles and neurodevelopmental disorders
Johnson, W. G. (2003) · BioEssays · doi:10.1002/bies.10268 · Cited by 28
Plasma cytokine response to surgical stress in schizophrenic patients
Kudoh, A., Sakai, T., Ishihara, H., & MATSUKI, A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01581.x · Cited by 26
Interacting impact of maternal inflammatory response and stress on the amygdala transcriptome of pigs
Keever-Keigher, M. R., Zhang, P., Bolt, C. R., Rymut, H. E., Antonson, A. M., Caputo, M. P., Houser, A. K., Hernandez, A. G., Southey, B. R., Rund, L. A., et al. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab113 · Cited by 25
Interleukin-2 Levels in Chronic Schizophrenia Patients
Mahendran, R., Mahendran, R., & Chan, Y. (2004) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v33n3p320 · Cited by 24
Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders
Kondo, T., Okada, Y., Saika, S., Yamaguchi, N., Hatakeyama, S., & Maruyama, K. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151418 · Cited by 24
Schizophrenia, rheumatoid arthritis and natural resistance genes
Rubinstein, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00023-6 · Cited by 23
DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders
Johnson, W. G. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4 · Cited by 33
The Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Severance, E. G., Tveiten, D., Lindström, L., Yolken, R. H., & Reichelt, K. L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160914183804 · Cited by 21
Schizophrenia among patients treated for rheumatoid arthritis and appendicitis
Lauerma, H., Lehtinen, V., Joukamaa, M., Järvelin, M., Helenius, H. Y. M., & Isohanni, M. K. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00098-4 · Cited by 21
The genetic basis for the inverse relationship between rheumatoid arthritis and schizophrenia
Zamanpoor, M., Ghaedi, H., & Omrani, M. D. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1483 · Cited by 19
How a Poliovirus Might Cause Schizophrenia: A Commentary on Eagles' Hypothesis
Squires, R. F. (1997) · Neurochemical Research · doi:10.1023/a:1022486423238 · Cited by 20
An enzyme/brain-barrier theory of psychiatric pathogenesis: Unifying observations on phenylketonuria, autism, schizophrenia and postpartum psychosis
Seim, A. R., & Reichelt, K. L. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90230-9 · Cited by 18
Decreased density of serotonin 5-HT2A receptors in rheumatoid arthritis
Kling, A., Rantapää-Dahlqvist, S., Stenlund, H., & Mjörndal, T. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042473 · Cited by 18
Disruption of Fetal Brain Development by Maternal Antibodies as an Etiological Factor in Schizophrenia
Laing, P., Knight, J. G., Wright, P., & Irving, W. L. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1955-3_14 · Cited by 18
Epidemiology of Schizophrenia
Eaton, W. W., Chen, C., & Bromet, E. J. (2011) · Wiley eBooks · doi:10.1002/9780470976739.ch16 · Cited by 18
Self-citation
Assessing whether the association between rheumatoid arthritis and schizophrenia is bidirectional: A nationwide population-based cohort study
Chen, S.-F., Wang, L.-Y., Chiang, J., Hsu, C. Y., & Shen, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-38149-3 · Cited by 15
Autoimmunity in neuropsychiatric disorders
Coutinho, E., & Vincent, A. C. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00015-3 · Cited by 14
The role of infections and inflammation in schizophrenia: review of the evidence
Ahmed, G. K., Ramadan, H. K., Elbeh, K., & Haridy, N. A. (2024) · Middle East Current Psychiatry · doi:10.1186/s43045-024-00397-7 · Cited by 16
Clinical Perspectives on Autoimmune Processes in Schizophrenia
Yum, S. Y., Yum, S. K., Kim, T., & Hwang, M. Y. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.09.003 · Cited by 14
HLA antigens in childhood onset schizophrenia
Jacobsen, L. K., Mittleman, B. B., Kumra, S., Lenane, M., Barracchini, K. C., Adams, S. D., Simonis, T. B., Lee, P. R., Long, R. T. L., Sharp, W. S., et al. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00015-8 · Cited by 14
Phospholipid, arachidonate and eicosanoid signaling in schizophrenia
Messamore, E., & Yao, J. K. (2015) · OCL · doi:10.1051/ocl/2015054 · Cited by 13
Plasma α1,3-Fucosyltransferase Deficiency in Schizophrenia
Yazawa, S., Tanaka, S., Nishimura, T., Miyanaga, K., & Kochibe, N. (1999) · Experimental and Clinical Immunogenetics · doi:10.1159/000019104 · Cited by 13
Immunologic profiling in schizophrenia and rheumatoid arthritis
Eaton, W. W., Rodriguez, K. M., Thomas, M. A., Johnson, J. H., Talor, M. V., Dohan, C. F., Bingham, C. O., Musci, R. J., Roth, K. B., Kelly, D. L., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114812 · Cited by 11
Self-citation
Membrane Pathology in Schizophrenia: Implication for Arachidonic Acid Signaling
Yao, J. K., & Reddy, R. K. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.870 · Cited by 12

Authors: Eaton, W. W., Hayward, C., & Ram, R.
Affiliations: Johns Hopkins University (US)
Stanford University (US)
State University of New York (US)
Corresponding author: Eaton, William W
ORCID: Eaton, William W
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 1992-03
Volume: 6
Issue: 3
Pages: 181-192
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/0920-9964(92)90001-l
OpenAlex: W1990840023
Cited by: 172
References: 120
Citations by year: 2024: 3 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 7 · 2014: 5 · 2013: 8 · 2012: 3
FWCI: 0.69
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4079 d)
Locations: Schizophrenia Research (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (44653, 44801)
National Institute of Mental Health
Topics: Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: schizophrenia, rheumatoid arthritis
MeSH terms: Arthritis, Rheumatoid, Cross-Sectional Studies, Humans, Risk Factors, Schizophrenia, Schizophrenic Psychology, United States, Comorbidity, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia and rheumatoid arthritis: a review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks